Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis.
Peters
M
M
I. Medizinische Klinik, Abteilung Pathophysiologie, Johannes Gutenberg Universität Mainz, Mainz, Germany; and Max Planck Institut für Immunbiologie, Freiburg, Germany.
Müller
A M
AM
Rose-John
S
S
D000818:Animals; D015703:Antigens, CD / Q000502:physiology*; D002454:Cell Differentiation; D050822:Cytokine Receptor gp130; D015198:Designer Drugs; D006410:Hematopoiesis / Q000502:physiology*; D006412:Hematopoietic Stem Cells / Q000502:physiology; D006801:Humans; D015850:Interleukin-6 / Q000032:analysis / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D008099:Liver / Q000166:cytology; D008562:Membrane Glycoproteins / Q000502:physiology*; D051379:Mice; D008822:Mice, Transgenic; D008958:Models, Molecular; D053683:Oncostatin M; D010455:Peptides / Q000494:pharmacology; D018123:Receptors, Interleukin / Q000032:analysis / Q000737:chemistry; D019947:Receptors, Interleukin-6 / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D011993:Recombinant Fusion Proteins / Q000032:analysis / Q000737:chemistry; D012995:Solubility; D013154:Spleen / Q000166:cytology; D013329:Structure-Activity Relationship
D015703:Antigens, CD; D015198:Designer Drugs; C494199:IL6ST protein, human; C494200:Il6st protein, mouse; D015850:Interleukin-6; D008562:Membrane Glycoproteins; C508351:OSM protein, human; C508352:Osm protein, mouse; D010455:Peptides; D018123:Receptors, Interleukin; D019947:Receptors, Interleukin-6; D011993:Recombinant Fusion Proteins; C104543:interleukin 6-interleukin 6 receptor fusion protein, recombinant; D053683:Oncostatin M; D050822:Cytokine Receptor gp130